VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
Illustration for: Morgan Stanley Amends Ethereum and Solana Trust Filings
Value Add VC/Pulse/IPO

Morgan Stanley Amends Ethereum and Solana Trust Filings

Morgan Stanley filed amended S-1s for both a Morgan Stanley Ethereum Trust and a Morgan Stanley Solana Trust, extending the spot-Bitcoin-ETF playbook to the next tier of large-cap tokens.

By the Numbers

2 amended S-1s
Filings
Ethereum, Solana
Assets
Morgan Stanley
Sponsor
TC
Trace Cohen
Early-stage VC & angel · Founder, New York Venture Partners
July 14, 2026
1 min read
ShareXLinkedInEmail

THE RUNDOWN

1

Morgan Stanley filed amended S-1/As for both a Morgan Stanley Ethereum Trust and a Morgan Stanley Solana Trust on July 14, moving two separate single-asset crypto investment vehicles closer to listing

2

The filings follow the precedent set by spot Bitcoin ETFs, which unlocked mainstream institutional access to crypto exposure after their 2024 approval, and extend that same wrapper to Ethereum and Solana specifically

3

A major bank filing for both an Ethereum and a Solana trust simultaneously signals Morgan Stanley sees institutional demand extending meaningfully beyond Bitcoin into the next tier of large-cap tokens

4

For crypto-infrastructure founders, dedicated bank-sponsored trusts are a durable institutional distribution channel that's structurally different from exchange-listed spot ETFs, and could pull incremental institutional capital into Ethereum and Solana specifically

TC

The VC Read · Trace's Take

Trace Cohen

Morgan Stanley filing for both an Ethereum and a Solana trust in the same week tells you institutional crypto demand has genuinely moved past a Bitcoin-only conversation, and a name like Morgan Stanley attaching itself to Solana specifically is a real credibility signal for a token that's spent years fighting a more speculative reputation. The wealth-management distribution angle here matters more than the trust structure itself -- that's incremental capital that wasn't going to show up in a spot ETF anyway.

Analysis

Morgan Stanley filed amended S-1/As for both a Morgan Stanley Ethereum Trust and a Morgan Stanley Solana Trust on July 14, moving two separate single-asset crypto investment vehicles closer to an actual listing. The filings extend a playbook first established by spot Bitcoin ETFs, which unlocked genuinely mainstream institutional access to crypto exposure following their approval, into the next tier of large-cap tokens.

The fact that a major bank is filing for both an Ethereum trust and a Solana trust simultaneously, rather than starting with just one asset, is itself a signal worth noting: Morgan Stanley evidently sees institutional demand extending meaningfully beyond Bitcoin, treating Ethereum and Solana as sufficiently established and liquid to warrant dedicated, bank-sponsored investment wrappers of their own.

“That's a meaningfully different capital-inflow mechanism than direct retail or crypto-native institutional buying.”

The competitive landscape includes existing spot ETH ETFs already trading from other issuers, meaning Morgan Stanley's trust structure would compete directly with established products rather than being first-to-market on Ethereum exposure specifically -- its differentiation would likely come from Morgan Stanley's own distribution network and existing wealth-management relationships rather than being a novel access point.

For crypto-infrastructure investors and founders, dedicated bank-sponsored trusts represent a distinct institutional distribution channel from exchange-listed spot ETFs, potentially reaching wealth-management clients who wouldn't otherwise directly purchase a crypto ETF on their own. That's a meaningfully different capital-inflow mechanism than direct retail or crypto-native institutional buying.

The bear case: amended S-1 filings don't guarantee SEC approval or a successful listing, and both Ethereum and Solana carry more regulatory ambiguity than Bitcoin around their classification, which could complicate or delay final approval relative to the more straightforward Bitcoin trust precedent. What to watch next: whether the SEC approves both trusts on a similar timeline, and how much assets under management they attract relative to existing spot ETH ETFs in their first months of trading.

ShareXLinkedInEmail

More on

Morgan Stanley →

Reported by SEC EDGAR · Analysis by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPO· Aug 9, 2026

What BofA's Extreme Bull Signal Means for Your Marks

Illustration for: What BofA's Extreme Bull Signal Means for Your Marks
IPO

What BofA's Extreme Bull Signal Means for Your Marks

BofA's Bull & Bear indicator hit 9.7, its highest since 2021 and above the firm's own 8.0 sell threshold — a trace's-take on what that extreme reading should change about how GPs mark portfolio companies against public comps.

IPO· Aug 8, 2026

Biotech IPOs Are Pricing Above Range Again

Illustration for: Biotech IPOs Are Pricing Above Range Again
IPO$532.5M combined

Biotech IPOs Are Pricing Above Range Again

BlossomHill and Braveheart Bio both upsized and priced above their original ranges this week, the clearest two-deal signal yet that the biotech IPO window -- closed to all but the strongest names in 2024-2025 -- is reopening.

IPO· Aug 7, 2026

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

Illustration for: BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq
IPO$150M IPO

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

BlossomHill Therapeutics priced an upsized IPO at $16 a share for $150M and began trading on Nasdaq under BLSM, more than 50% above the $100M target Pulse flagged when the company first filed.

@Trace_Cohen·t@nyvp.com